MAY 29, 2018 09:00 AM PDT

Dissecting the Tumor Microenvironment Part 2 - Tools for isolation and flow analysis

SPONSORED BY: Miltenyi Biotec
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Team Coordinator, Miltenyi Biotec
    Biography
      Dr. César Evaristo received his Ph.D. at the University of Paris Descartes, Paris, France in 2009. After 7 years as a research scientist in the US and Germany he joined Miltenyi Biotec in 2016 as a Team Coordinator of the R&D Tumor Immunology Group. He focuses on immuno-oncology preclinical research, target discovery, as well as oncology related product development.

    Abstract:

    DATE: May 29, 2018
    TIME: 9:00AM PDT, 5:00PM CET

    Isolation of tumor infiltrating leukocytes (TILs) and optimized workflow for faster and improved flow analysis

    Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells within the tumor microenvironment is key to developing future immune based cancer therapy strategies. However, the most significant challenge to working with solid tumors is the need to dissociate the samples prior to their use in downstream applications such as immunomagnetic enrichment, flow cytometry and single-cell sequencing. Furthermore tumor cells can cause background signals and introduce bias to the analysis of immune cells.

    Learning Objectives:

    •    Optimized workflows for isolation and flow cytometric phenotyping of mouse TILs
    •    Best tools and solutions to increase the quality of the data, reduce experimental time and ease of scale up during TIL analysis using flow cytometry
    •    Best methods for reducing biases during TIL analysis

     

     


    Show Resources
    You May Also Like
    NOV 18, 2019 07:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    DEC 10, 2019 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 10, 2019 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    Loading Comments...
    Show Resources